Sof-TactTM, Breakthrough Alternate-Site Glucose Monitoring Technology Now Available for People with Diabetes
12-Apr-2001 -
Abbott Laboratories, MediSense Products announced today the availability of Sof-Tact™, the first automated alternate-site glucose monitoring system to provide virtually painless, one-step testing. For the more than 16 million people with diabetes in the United States, Sof-Tact offers a simpler, ...
Abbott
clinical trials
glucose
+1